Viewing StudyNCT03583333

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03583333
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2018-06-28
Brief Title: ImipenemCilastatinRelebactam MK-7655A Versus PiperacillinTazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia MK-7655A-016
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Ventilator-Associated Bacterial Pneumonia
Hospital-Acquired Bacterial Pneumonia
Keywords: